Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of different dosing intervals of sifuvirtide in HIV infection
ChiCTR-IPR-15006316Phase 2Recruiting
- Sponsor
- Beijing YouAn Hospital
- Start
- Apr 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, open-label trial of sifuvirtide in human immunodeficiency virus infection (HIV) and acquired immunodeficiency syndrome (AIDS) (2 arms), sponsored by Beijing YouAn Hospital. Primary endpoints: viral load and safety indexes. Started Apr 2015; status: recruiting.
02
Drugs
sifuvirtide
03
Conditions
human immunodeficiency virus infection (HIV)acquired immunodeficiency syndrome (AIDS)
Beyond the preview
Go deeper on ChiCTR-IPR-15006316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006316.